Status:
COMPLETED
PLATINUM Diversity
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Atherosclerosis
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
To compile acute procedural performance and clinical outcomes data for the Promus PREMIER everolimus-eluting coronary stent system in understudied/underserved patient populations including women and m...
Eligibility Criteria
Inclusion
- Patient must be at least 18 years of age
- Patient must sign informed consent form
- Patient has received at least one Promus PREMIER stent
- Patient self-identifies as one or more of the following:
- Female
- Black of African Heritage
- Hispanic/Latino
- American Indian or Alaska native
Exclusion
- Not applicable
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
1501 Patients enrolled
Trial Details
Trial ID
NCT02240810
Start Date
October 1 2014
End Date
December 1 2016
Last Update
May 15 2019
Active Locations (52)
Enter a location and click search to find clinical trials sorted by distance.
1
St Luke's Medical Center
Phoenix, Arizona, United States, 85006
2
St Bernards Heart and Vascular
Jonesboro, Arkansas, United States, 72401
3
Arkansas Cardiology/Baptist Health Medical Center
Little Rock, Arkansas, United States, 72205
4
Central Cardiology Medical Clinic
Bakersfield, California, United States, 93308